Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New MS research shows remarkable findings

05.02.2004


New research findings from the Research Institute of the McGill University Health Center (MUHC) provide hope for patients with multiple sclerosis (MS), one of the most common and devastating diseases of the nervous system. These findings, published in today in Neuron, characterize an enzyme that plays a central role in the onset and progress of MS.

" We have identified a key enzyme that triggers MS-like disease in an animal model," says MUHC neuroscientist and Professor of Medicine at McGill University, Dr. Sam David. "We also show that blocking this enzyme has a remarkable effect in preventing disease and relapses."

MS, an autoimmune disease of the nervous system, affects approximately 35,000 young adults in Canada. It is twice as prevalent in females. MS is an inflammatory disease in which the body’s own immune system attacks the insulating membranes surrounding nerve fibers. This damage results in loss of sensations and paralysis. Although genetic, infectious or environmental factors are thought to induce MS, the exact cause of the disease is still not known.



Dr. David with his Ph.D. student Athena Kalyvas showed in a mouse model of MS that the amount of the enzyme, phospholipase A2 (cPLA2), is increased in spinal cord lesions. They further demonstrated that treatment with a chemical inhibitor of this enzyme results in a marked reduction in the onset and severity of the disease.

"This discovery suggests that the cPLA2 enzyme may be an excellent target for the development of drugs to treat MS, " concluded Dr. David.


This work was supported by funds from the Multiple Sclerosis Society of Canada.

For Information contact:
MUHC Public Relations and Communications:
Christine Zeindler
Communications Coordinator (Research)
(514) 934-1934 ext. 36419
pager: (514) 406-1577

Christine Zeindler | McGill University
Further information:
http://www.mcgill.ca/

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Shrews shrink in winter and regrow in spring

24.10.2017 | Life Sciences

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>